FDA's Foray Into Big Data Still Maturing

With access to claims data on about 200 million patients and 5.5 billion patient encounters across the United States, the US Food and Drug Administration’s (FDA’s) Sentinel Initiative has grown into a juggernaut of patient experience since its pilot program launched in 2008.